American Century Companies Inc Stoke Therapeutics, Inc. Transaction History

American Century Companies Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$11.03 - $17.52 $325,263 - $516,647	29,489 Added 99.42%	59,149 $799,000
Q1 2024 May 14, 2024	BUY	$4.12 - $14.17 $35,530 - $122,202	8,624 Added 41.0%	29,660 $400,000
Q4 2023 Feb 13, 2024	BUY	$3.37 - $5.4 $70,891 - $113,594	21,036 New	21,036 $110,000
Q3 2023 Nov 13, 2023	BUY	$3.78 - $11.99 $61,020 - $193,554	16,143 New	16,143 $63,000
Q1 2020 May 14, 2020	SELL	$16.8 - $34.15 $2.41 Million - $4.89 Million	-143,327 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$20.01 - $30.79 $1.09 Million - $1.68 Million	54,572 Added 61.49%	143,327 $4.06 Million
Q3 2019 Nov 13, 2019	SELL	$20.53 - $37.72 $331,107 - $608,348	-16,128 Reduced 15.38%	88,755 $1.91 Million
Q2 2019 Aug 14, 2019	BUY	$25.53 - $29.17 $2.68 Million - $3.06 Million	104,883 New	104,883 $3.06 Million

123

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $474M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.